BD Stock Information and Performance

BD stock, also known as Becton Dickinson and Company, is a well-established medical technology company with a long history of innovation.

BD stock symbol is BDX, and it's listed on the New York Stock Exchange (NYSE). The company was founded in 1897 by two brothers, Edward and John Dickinson.

BD has a diverse portfolio of products and services, including medical devices, diagnostic systems, and pharmaceutical packaging solutions. They have a strong presence in the global healthcare market.

BD's stock performance has been impressive over the years, with a consistent track record of growth and stability.

If this caught your attention, see: Stock Symbol B

In 2024, BDX's revenue was a significant $20.18 billion, marking a 4.16% increase from the previous year.

This substantial growth in revenue was accompanied by a notable increase in earnings, which reached $1.71 billion, a 19.73% jump.

The impressive financial performance of BDX in 2024 is a testament to the company's continued success and growth in the medical technology sector.

Becton & Co. Q2 2021 Earnings Call was for the period ending March 31, 2021. Becton Dickinson & Co. held a Q2 2021 earnings call. The earnings call was a significant event for the company. It provided investors and analysts with valuable insights into the company's financial performance. Becton Dickinson & Co. is a well-established company with a strong presence in the healthcare industry. The company's Q2 2021 earnings call was a critical moment for the company.

Becton & Co. Q1 2021 Earnings Call was for the period ending December 31, 2020. This was announced by Becton Dickinson & Co. (BDX) during their Q1 2021 Earnings Call Transcript.

The earnings call was a significant event for investors and stakeholders. Becton Dickinson & Co. (BDX) reported their financial performance for the quarter.

The company's financial results for Q1 2021 were a crucial aspect of the earnings call. Becton Dickinson & Co. (BDX) had just ended the fiscal year of 2020.

Suggestion: Brighthouse Financial Ticker Symbol

Let's take a closer look at the financial strength of these companies. BDX, BAX, and RHHBY all have a quick ratio, which indicates their ability to pay off short-term debts. BDX's quick ratio is 0.44, which is relatively low compared to the others.

Their current ratio, on the other hand, is a better indicator of their liquidity. BDX has a current ratio of 1.13, which means it can cover its short-term debts, but just barely. BAX has a much higher current ratio of 1.36, indicating that it has a strong ability to pay off its debts.

Interest coverage is another important metric. BDX has an interest coverage ratio of 4.15, which means it can cover its interest payments with its earnings. BAX, however, has a much lower interest coverage ratio of 0.13, indicating that it may struggle to make its interest payments.

Here's a comparison of the financial strength of these companies:

RHHBY stands out with its strong financial strength, having a quick ratio of 0.80 and an interest coverage ratio of 11.62. This suggests that it has a strong ability to pay off its debts and make its interest payments.

As an investor, it's essential to stay informed about the financial health of a company before making a decision. The revenue growth of Becton, Dickinson (BD) is impressive, with estimated revenue increasing from $21,837 million in 2025 to $25,178 million in 2028.

BD's dividend yield has been steadily decreasing, from 1.68% in 2025 to 1.21% in 2027. This could be a concern for income investors.

The company's earnings per share (EPS) are expected to grow from $14.42 in 2025 to $17.84 in 2028, indicating a strong financial performance.

Here's a breakdown of BD's estimated financial performance for the next few years:

BD's net profit is expected to increase from $4,173 million in 2025 to $5,173 million in 2028, indicating a strong financial performance.

The company's cash flow from operations is expected to increase from $3,946 million in 2025 to $4,443 million in 2027, which is a positive sign for investors.

BD's research and development expenses are expected to increase from $1,236 million in 2025 to $1,297 million in 2028, indicating a commitment to innovation.

The number of analysts estimating BD's earnings has increased from 10 in the current quarter to 14 in the next year, indicating a growing interest in the company's financial performance.

The bd stock symbol is listed on the NASDAQ stock exchange, which is a major electronic marketplace for buying and selling securities.

The company has a market capitalization of over $10 billion, making it a significant player in the industry.

The bd stock symbol has seen significant volatility in recent years, with a high of $150 per share and a low of $50 per share.

Becton Dickinson's share price has seen its fair share of ups and downs over the years.

The current share price is $230.31, which is a significant drop from the 52-week high of $251.99.

For your interest: T Rowe Price Ticker Symbols

BDX's 52-week low was $218.75, showing that the company's stock has been volatile in the past year.

With a beta of 0.43, BDX's stock is considered relatively stable compared to the overall market.

Over the past 1 month, the stock has seen a decline of 5.40%, while over the past 3 months, it has increased by 2.70%.

In the past year, the stock has decreased by 4.72%, and over the past 5 years, it has decreased by 6.12%.

Here's a summary of BDX's price changes over the years:

Shares of Becton, Dickinson rose on Monday due to a company announcement.

The Alaris Infusion System is a key product for the company.

The updated version of the Alaris Infusion System will be relaunched, which contributed to the stock's rise.

BD stock symbol is a popular choice among investors, and for good reason - it's a dividend-paying stock. BD is a well-established company with a long history of paying consistent dividends to its shareholders.

One of the key benefits of investing in BD stock is the company's commitment to returning value to its shareholders through dividends. BD has increased its dividend payout for 47 consecutive years.

As a shareholder, you can expect to receive a dividend payment on a regular basis, typically quarterly. This can be a great way to earn a steady stream of income from your investment.

Becton, Dickinson & Co. has a long history of paying dividends to its shareholders. The company's dividend calendar is a valuable resource for investors, providing a clear picture of the company's dividend payments over the years.

The dividend calendar shows that Becton, Dickinson & Co. has consistently paid dividends since 1999, with the first recorded dividend payment being $0.34 in 1999. This indicates a commitment to returning value to shareholders.

The dividend payments have increased steadily over the years, with the highest payment being $3.80 in 2024. This represents a significant increase from the initial payment in 1999.

Here is a summary of the dividend payments made by Becton, Dickinson & Co. over the years:

The dividend yield has also fluctuated over the years, ranging from a low of 1.11% in 2003 to a high of 1.98% in 2013.

As a shareholder, you're likely interested in how your investment in Becton Dickinson (BDX) is performing compared to the broader market and its industry peers.

In the past 7 days, BDX returned 2.5%, which is a significant improvement over the US Medical Equipment industry's 0.08% return. The US Market, however, saw a decline of 3.0% over the same period.

Here's a comparison of BDX's performance over the past year:

As you can see, BDX underperformed the US Medical Equipment industry, which returned 11.7% over the past year, and also underperformed the US Market, which returned 17.8% over the same period.

Looking at the company's performance over the past 5 years, we can see that BDX's 1-year return of -4.87% was lower than the S&P's 1-year return of 17.58%. However, BDX's 5-year return of 3.19% was higher than the S&P's 5-year return of 91.99%.

Readers also liked: Bausch and Lomb Stock Symbol

Becton, Dickinson has a history of releasing quarterly earnings reports, with the actual earnings per share (EPS) varying over time. The company's Q1 2025 earnings release is expected to be around 1.040 USD.

In the past, the company has held annual general meetings, with the most recent one being on January 28, 2025, where the actual EPS was 5.860 USD. This meeting is a significant event for shareholders.

The company's quarterly earnings reports have shown a range of actual EPS values, from 0.370 USD in Q4 2023 to 2.280 USD in Q1 2022. The Q2 2024 earnings release had an actual EPS of 1.680 USD.

Here is a list of the company's quarterly earnings reports, along with their actual EPS values: